SPMS is one of the four universally known types of multiple sclerosis. In this disease form, there is a rapid neurological damage which may be accompanied by relapses and remissions. People with SPMS would have undergone a phase of Relapsing/Remitting Multiple Sclerosis (RRMS) lasting from two to more years. The damage is rapid in this stage of disease but rate of increased disability varies among people.

In the SPMS form, lesions formation is decreased than in RRMS but general deterioration continues. This may be due to greater loss of axonal. SPSS patients form 30% of the total Multiple Sclerosis population. Reasons for progression of disability from the beginning of disease to its secondary state are still not known fully. The advanced forms of MS have not yielded to treatment. The affect of legendary immunosuppresion as a treatment has been at best, meagre. So far, interferons and glatiramer have proved effective. Clinical Results have shown positive effect of these drugs on chronic patients.

In case of MS, the crux lies in overall management of disease. Being a debilitating disease, it causes inconsistent bladder movements, pain, depression, fatigue, sexual dysfunction, tremor, paroxysmal disorders and heat intolerance. A holistic system of disease management may reduce the trauma.

Treatment

Interferon beta-1b is most common treatment for SPMS and has been seen to significantly reduce the progression of disease-linked disability. Interferons help in regulating immune system of the body. In SPMS, it restricts the activities of disease causing white-blood cells. As a result of this medication, there is a significant difference in time between relapses. The size of lesions is also diminished, as a result. It is taken in injectible dose and side effects include flu-like symptoms and reaction around injection area. In certain cases, patients do not respond to interferons. If a patient does not respond to interferon after being treated for 6 months, it is obvious that interferon is not working. The body may have produced neutralizing antibodies to interferon. Another disadvantage is that interferon is an expensive drug.
Mitoxantrone is known to restrain certain cells of the body that destroy myelin in central nervous system.

As a result, rate of relapse gets delayed and progression of disability is reduced. Mitoxantrone (Novantrone) has shown effectiveness in PMS although its side effects can cause severe complications. It is a chemotherapy medication and is given intravenously every three month. It can also be given on monthly basis depending on the severity of the disease. The side effects include potential toxicities including cardiac toxicity. A cardiologist's opinion should be sought before starting the medication of Mitoxantrone.

In addition, muscle relaxants, Anticholiergics, Urinary Tract Antispasmodics, anticonvulsants, central nervous system stimulant, antidepressants; NSAIDS can be used to combat common symptoms of MS.

Studies have shown that multiple sclerosis is very hard on people affecting some 2 in every 1000 persons. Even more problematic is the fact that some 50 % of these people are left unable to walk after some 15 from the onset of the disorder. A total cure has not yet been developed but scientists and doctors are working on treatments that will at least slow down the action of the disease. The good thing is that they really are starting to understand how the disorder works and the way it affects people, plus a new kind of monitor treatment is being developed as we speak. The bases for some new treatments have this way been developed; they include the using of disease modifying drugs that will have quite a remarkable impact on the natural course of the disease, significantly slowing it down.

Still some of these drugs are yet to be approved and clinical test are still in progress to really understand if the drugs are working and what the side effects would be. Scientist and doctors from all over the world gather more and more often to discuss their new findings and believes regarding multiple sclerosis. Because of all this effort put into defeating this disease a lot of progress has been made.

It has been seen that the disorder starts manifesting itself clinically in patients after a period of about 5 years when the disease enters the secondary progressive phase. Physical symptoms are more clear now and start affecting the patient on a regular bases, each time stronger than the last. Relapsing- remitting patients have shown to have a benign course of the disease developing little or no affect from disabilities after a period of about 10 years. Trying to predict the appearance and actions of the disabilities in the cases of multiple sclerosis patients has proven to be a major challenge for doctors. The fact is that this disorder is very variable and has a sudden way of acting.

Tests and researches done by scientist have shown that there actually are some factors that make prognosis in multiple sclerosis quite unfavorable. Male sex has been proven to be one of the grater factors to affect prognosis; also the age at witch the disease begins its onset. Some motor and cerebral signs that are present on the onset might be also be affecting the prognosis. A very confusing fact for the doctors is the rate at witch the patient has its attacks ( short intervals pose a great problem), and also the high relapse rate in the early years of the disease. Incomplete recovery after relapses can also cause a great problem if the doctors are to correctly anticipate the path of the disease.